Clinical trial
MRI to Detect Breast Tumors in Women
NCT00003302 · Abramson Cancer Center at Penn Medicine, Other · Completed
Key facts
| NCT number | NCT00003302 |
|---|---|
| Title | MRI to Detect Breast Tumors in Women |
| Official title | Breast MRI Protocol |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Diagnostic Test, Procedure |
| Interventions | biopsy, magnetic resonance imaging, mammography |
| Enrollment | 1,500 |
| Start date | May 1, 1998 |
| Primary completion | Jun 30, 2000 |
| Completion | Jun 30, 2000 |
| First posted | Mar 1, 2004 |
| Last update posted | Sep 25, 2019 |
| Countries | Canada, Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: